Fact Sheet for Healthcare Providers: Beckman Coulter, Inc. Access SARS-CoV-2 IgG | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: Beckman Coulter, Inc. Access SARS-CoV-2 IgG

06/26/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/26/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of Access SARS-CoV-2 IgG. Access SARS-CoV-2 IgG is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum, serum separator tubes, and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, sodium citrate). (PDF)